Frequently Asked Questions
Drugs for Schistosomiasis market has been impacted notably with decline in market size by 10%. COVID 19 affected the production, logistics and distribution of drugs for Schistosomiasis resulting into significant losses for the industry participants
Major players mapped in the report include but not limited to the Bayer AG, Chandra Bhagat Pharma Ltd, EIPICO, Merck & Co Inc and Pfizer Inc.
Hospital’s segment is marching at a rapid pace and likely to keep its dominance over the forecast period
Middle East & Africa was leading geographic market for the drugs for Schistosomiasis, reason being the highest prevalence rate of Schistosomiasis in the region
The global Drugs for Schistosomiasis market report provide CAGR of 5.6% from 2021 to 2027